[The use of hemoperfusion through a suspension of cryopreserved hepatocytes in acute liver failure].
The present work deals with results of intensive therapy and temporary organ substitution by using hemoperfusion through a suspension of living donor hepatocytes in 71 patients with acute hepatic insufficiency. Hemoperfusion was performed through a suspension of fresh living hepatocytes or through a suspension of cryo-conserved (during 60 days) living hepatocytes. Lethality was 37-42%.
Margulis
M S
MS
Erukhimov
E A
EA
Andreĭman
L A
LA
Kuznetsov
K A
KA
Viksna
L M
LM
Kuznetsov
A I
AI
Deviatov
V V
VV
D000818:Animals; D015925:Cryopreservation; D005069:Evaluation Studies as Topic; D006464:Hemoperfusion / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D008099:Liver / Q000166:cytology*; D017114:Liver Failure, Acute / Q000628:therapy*; D012074:Remission Induction; D013552:Swine; D014021:Tissue Preservation
Primenenie gemoperfuzii cherez vzves' kriokonservirovannykh gepatotsitov pri ostroĭ pechenochnoĭ nedostatochnosti.